These studies also present GLUT1 as an overall metabolic marker for the pancreatic cancer cells, whereas, IDH3A may serve as an overall marker for the lung metastatic lesions of pancreatic adenocarcinoma. The gene discussed is SLC2A1; the disease is familial pancreatic carcinoma.